Friday 6 November 2026 Export PLYX’s income statement to Excel — free account

Polaryx Therapeutics, Inc.

PLYX Healthcare Biotechnology

Insider buying

1.80 0.00 0.00%

Follow PLYX

Alert me

Market cap: $86.7M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview

	Older periods	Jun '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+2 more TTM periods Free account	—	—	—	0.00%
ROA Full definition →		—	—	0.00%	(169.05%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		—	0.00%	0.00%	(91.27%)
Free Cash Flow per Share Full definition →		0.00	0.00	(0.16)	(0.17)
Free Cash Flow Full definition →		—	(8.08)	(7.57)	(8.23)
Other line items
Cash ROIC Full definition →		0.00%	(83.27%)	(136.03%)	(36.63%)
Average Days of Payables Full definition →		—	0.00	0.00	0.00
Tax Rate Full definition →		—	—	—	0.00
Research and Development Expense of Revenue Full definition →		—	—	—	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		—	—	—	0.00%
Share Based Compensation of Revenue Full definition →		—	—	—	0.00%
Operating CF/Net income Full definition →		—	0.00	0.00	0.82
Revenue per Share Full definition →		0.00	—	0.00	0.00
Operating CF per Share Full definition →		0.00	0.00	(0.16)	(0.17)
Capex per Share Full definition →		0.00	—	0.00	0.00

Show all line items

Columns are period end dates